ARCA biopharma (ORKA) P/E (2010 - 2026)
ARCA biopharma (ORKA) P/E from Dec 31, 2010 to Jul 21, 2026. The TTM ARCA biopharma (ORKA) P/E is -37.38. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ARCA biopharma (ORKA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -37.38 | +202.13% |
| 2025 | -12.37 | +63.63% |
| 2024 | -7.56 | -86.06% |
| 2023 | -54.24 | +90.97% |
| 2022 | -28.40 | +12.94% |
| 2021 | -25.15 | -24.94% |
| 2020 | -33.50 | +48.24% |
| 2019 | -22.60 | +208.58% |
| 2018 | -7.32 | +0.66% |
| 2017 | -7.28 | -38.17% |
| 2016 | -11.77 | -32.53% |
| 2015 | -17.44 | +24.91% |
| 2014 | -13.96 | +7.05% |
| 2013 | -13.04 | +308.02% |
| 2012 | -3.20 | -73.04% |
| 2011 | -11.86 | -82.19% |
| 2010 | -66.58 | N/A |
Comparison ARCA biopharma (ORKA) P/E with competitors
ARCA biopharma (ORKA) P/E is -37.38.